A phase 1 study of ABL-101
Latest Information Update: 09 Jul 2021
Price :
$35 *
At a glance
- Drugs ABL 101 ABL-Bio (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
- 09 Jul 2021 New trial record
- 14 May 2021 According to an ABL Bio media release, the company plans to proceed with IND filing early next year to initiate this study.